Aviaar Medicaments Private Limited
About Aviaar Medicaments Private Limited
Data last updated:
Aviaar Medicaments Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 February 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2022PTC159940.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priyanka Pandey and Anand Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 647 C/155 Kiran Garden Society Behind Sahara Estate Jankipuram, Lucknow, Uttar Pradesh, India – 226021.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.29 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹1.6 Lakh (net margin -48.8%) and EBITDA of -₹1.6 Lakh (EBITDA margin -48.8%).
Company details
Contact details
Aviaar Medicaments Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressH. No. 647 C/155 Kiran Garden Society Behind Sahara Estate Jankipuram, Lucknow, Uttar Pradesh, India – 226021
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aviaar Medicaments is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aviaar Medicaments Private Limited, buy the company report.
Financials of Aviaar Medicaments Private Limited
FY 2025 filings availableAviaar Medicaments Private Limited reported revenue of ₹3.29 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year. EBITDA fell 40% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.6 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.6 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -48.8% | |||
| Net Profit Margin | -48.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aviaar Medicaments Private Limited, buy the company report.
Board of directors of Aviaar Medicaments Private Limited
Aviaar Medicaments has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Pandey | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
| Anand Kumar Pandey | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Aviaar Medicaments Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fuzoku Marketing & Consulting Private Limited | ₹3.29 Lakh (FY 2024) | -84.0% | New Delhi, Delhi, India | |||
| Asada Corporation India Private Limited | ₹3.29 Lakh (FY 2024) | -98.0% | Mumbai, Maharashtra, India | |||
| Pharma Art Private Limited | ₹3.29 Lakh (FY 2022) | Thatipur, Madhya Pradesh, India | ||||
| Utsav Engineering. Co. Private Limited | ₹3.29 Lakh (FY 2019) | -81.0% | New Delhi, Delhi, India | |||
| Avni Enterprises Private Limited | ₹3.29 Lakh (FY 2024) | 14.0% | Kolkata, West Bengal, India | |||
| Aviaar Medicaments Private Limitedthis company | ₹3.29 Lakh (FY 2025) | -₹1.6 Lakh | -48.8% | -11.0% | Lucknow, Uttar Pradesh, India | |
| Karvinya Organic Farm Private Limited | ₹3.28 Lakh (FY 2022) | -16.0% | Chennai, Tamil Nadu, India | |||
| Aditya Av Metals & Plastics Private Limited | ₹3.28 Lakh (FY 2024) | Varanasi, Uttar Pradesh, India | ||||
| Niladri Marketing Private Limited | ₹3.28 Lakh (FY 2019) | -23.0% | Bhubaneswar, Odisha, India | |||
| Ramdeobaba Impex Private Limited | ₹3.28 Lakh (FY 2019) | -7.0% | Nagpur, Maharashtra, India | |||
| Asadpur Saidpura Farmer Producer Company Limited | ₹3.28 Lakh (FY 2022) | 6.0% | Vaishali, Bihar, India |
To see the full peer comparison of Aviaar Medicaments Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aviaar Medicaments Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aviaar Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aviaar Medicaments Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aviaar Medicaments Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Anand Kumar Pandey was appointed as Director on 22 Feb 2022.
Frequently asked questions
Aviaar Medicaments is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 February 2022 (4+ years old) and is registered under CIN U24100UP2022PTC159940.
Aviaar Medicaments has 2 current directors:
- Priyanka Pandey - Director
- Anand Kumar Pandey - Director
The latest financial statements of Aviaar Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Aviaar Medicaments is U24100UP2022PTC159940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aviaar Medicaments was incorporated on 22 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Aviaar Medicaments by revenue are Fuzoku Marketing & Consulting Private Limited, Asada Corporation India Private Limited, Pharma Art Private Limited, Utsav Engineering. Co. Private Limited, Avni Enterprises Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anand Kumar Pandey was appointed as Director on 22 Feb 2022. Priyanka Pandey was appointed as Director on 22 Feb 2022.
The registered office of Aviaar Medicaments is at H. No. 647 C155 Kiran Garden Society Behind Sahara Estate Jankipuram, Lucknow, Uttar Pradesh, India – 226021.
Aviaar Medicaments operates in the chemicals industry, in the manufacturing segment.
Aviaar Medicaments can be reached at its registered office: H. No. 647 C155 Kiran Garden Society Behind Sahara Estate Jankipuram, Lucknow, Uttar Pradesh, India – 226021.
Aviaar Medicaments is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
